Comparing Treatments Using Quality-Adjusted Survival: The Q-TWiST Method
暂无分享,去创建一个
R. Gelber | A. Goldhirsch | S. Gelber | B. Cole | Richard D. Gelber | Aron Goldhirsch | Bernard F. Cole | Shari Gelber
[1] R. Gelber,et al. A quality-adjusted survival meta-analysis of adjuvant chemotherapy for premenopausal breast cancer. International Breast Cancer Study Group. , 1995, Statistics in medicine.
[2] R. Salama. IMMUNITY AND CYSTIC FIBROSIS. , 1965, Lancet.
[3] M. Baum,et al. EVALUATION OF QUALITY OF LIFE IN PATIENTS RECEIVING TREATMENT FOR ADVANCED BREAST CANCER , 1976, The Lancet.
[4] R. Sanson-Fisher,et al. Measuring quality of life in cancer patients. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] R. Gelber,et al. Evaluation of effectiveness: Q-TWiST , 1993 .
[6] R. Gelber,et al. Parametric approaches to quality-adjusted survival analysis. International Breast Cancer Study Group. , 1994, Biometrics.
[7] P Glasziou,et al. Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] M A Fischl,et al. Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. The AIDS Clinical Trials Group. , 1992, Annals of internal medicine.
[9] N. Breslow,et al. A Large Sample Study of the Life Table and Product Limit Estimates Under Random Censorship , 1974 .
[10] Richard D. Gelber,et al. A quality-of-life-oriented endpoint for comparing therapies. , 1989 .
[11] David R. Cox,et al. Quality‐Of‐Life Assessment: Can We Keep it Simple? , 1992 .
[12] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[13] R. Gelber,et al. Parametric extrapolation of survival estimates with applications to quality of life evaluation of treatments. International Breast Cancer Study Group. , 1993, Controlled clinical trials.
[14] R. Gelber,et al. A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] P. Volberding,et al. Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group. , 1994, The New England journal of medicine.
[16] G. Torrance. Measurement of health state utilities for economic appraisal. , 1986, Journal of health economics.
[17] F. Cavalli,et al. Quality-of-Life-Adjusted Evaluation of Adjuvant Therapies for Operable Breast Cancer , 1991 .
[18] M. Schumacher,et al. Assessment of quality of life in clinical trials. , 1991, Statistics in medicine.
[19] R. Gelber,et al. Cox regression models for quality adjusted survival analysis. , 1993, Statistics in medicine.
[20] P. Selby,et al. Assessing quality of life in cancer patients. , 1989, British Journal of Cancer.
[21] R. Gelber,et al. Quality adjusted survival analysis. , 1990, Statistics in medicine.
[22] R. Gelber,et al. Quality of life in clinical trials of adjuvant therapies. International Breast Cancer Study Group (formerly Ludwig Group). , 1992, Journal of the National Cancer Institute. Monographs.
[23] C. Moinpour,et al. Quality of life end points in cancer clinical trials: review and recommendations. , 1989, Journal of the National Cancer Institute.